A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
Phase 1 study testing SRP-1005 in Huntington's disease.
RecruitingPhase 1DrugClinicalTrials.govTreatment trial
Recruiting in: Cardiff, Christchurch, Gümligen +1 more (Australia, New Zealand, Switzerland +1 more)
Sponsor: Sarepta Therapeutics, Inc.
Preparing a short plain-English summary.